Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Data
- Doc file
Supplementary Figure
- tif file
Supplementary Table 1
- doc file
Supplementary Table 3
- doc file
Supplementary Table 4
- doc file